Our product, Nichi glucan, has been published in NutraIngredients-Asia, which is a collection of information on functional foods and suppliments in Asia and the Middle East.
It reports that a clinical trial has started in India to use Nichi glucan as an adjunct in the treatment of Covid-19 patients.
To read the NutraIngredients-Asia article, please click here.
Please visit nichiglucan.com for more information about Nichi Glucan.
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Manuscript published in Stem Cell Reviews and Reports
